Asha Syed
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Asha Syed has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
C. Muddu Krishna
Department of Biotechnology, VFSTR (Deemed to be University), Vadlamudi, Guntur, AP, India
2 shared publicationsT. Sravan Kumar Reddy
Discovery Biology, Hetero Research Foundation, Hyderabad, Telangana, India
2 shared publicationsB Sasi Reka
VFSTRU (Deemed to be University)
1 shared publicationB. Tazneem
Deccan School of Pharmacy, Hyderabad, India
1 shared publicationBhargavi Maddineni
Department of Biotechnology, School of Biotechnology and Pharmaceutical Sciences, Vignan’s Foundation for Science, Technology and Research (Deemed to be University), Vadlamudi, Guntur 522 213, Andhra Pradesh, India
1 shared publicationC. Umamaheswari
1 shared publication
Latest Publications
- 14 November 2024
- Published by Elsevier in South African Journal of Botany
- Vol. 175, 761-769
Isolation and characterization of phytochemicals from leaf extract of Memecylon lushingtonii Gamble and their evaluation for biological properties
- 14 November 2024
- Published by Elsevier in South African Journal of Botany
- Vol. 175, 761-769
Isolation and characterization of phytochemicals from leaf extract of Memecylon lushingtonii Gamble and their evaluation for biological properties
- Open Access
- 4 August 2023
- Published by Manuscript Technomedia LLP in Current Trends in Biotechnology and Pharmacy
- Vol. 17 (3) , 946-958
Identification of Bioactive Compounds from Leaf Methanolic Extracts of Adhatoda vasica (L.) Nees and Psidium guajava L. by GC-MS Profiling
While Adhatoda vasica (Vasaka) is an important medicinal plant used as a remedy for treating bronchitis, tuberculosis and other lung disorders, Psidium guajava (Guava) is used against diabetes, diarrhea, dysentery, gastroenteritis and hypertension. We report here the methanolic extract and phytochemical analysis of both the plants from the leaves using gas-chromatography (GC) and mass spectrometry (MS). Analysis of vasaka revealed the presence of amrinone, a selective phosphodiesterase III inhibitor effective in the treatment of congestive heart failure; silicic acid associated with bone mineralization, collagen synthesis, skin, hair and nails health atherosclerosis, Alzheimer disease, immune booster; arsenous acid used for treating leukemia; methyltris (trimethylsiloxy)silane which is a potent antibacterial compound; tetrasiloxanedecamethyl- that exhibits antifungal activity. Analysis of guava revealed the presence of copaene (a tricyclic sesquiterpene) that has antioxidant activity, caryophyllene oxide which has relaxation effect, humulene that promotes appetite-suppressing effect and used for weight loss, γ-muurolene that is known for its antibacterial activity and also alloaromadendrene, a sesquiterpenoid with anticancer and antibacterial properties. Importantly, it also contains (±)-norephedrine, an appetite suppressant and used for nasal decongestion. Phenylephrine is used to relieve nasal discomfort caused by colds, allergies, and hay fever, and (-)-isolongifolol, an antioxidant. The data show that both the plants have important bioactive molecules that can be further exploited for treating human ailments.
- 4 August 2023
- Published by Manuscript Technomedia LLP in Current Trends in Biotechnology and Pharmacy
- Vol. 17 (3) , 946-958
Open AccessIdentification of Bioactive Compounds from Leaf Methanolic Extracts of Adhatoda vasica (L.) Nees and Psidium guajava L. by GC-MS Profiling
While Adhatoda vasica (Vasaka) is an important medicinal plant used as a remedy for treating bronchitis, tuberculosis and other lung disorders, Psidium guajava (Guava) is used against diabetes, diarrhea, dysentery, gastroenteritis and hypertension. We report here the methanolic extract and phytochemical analysis of both the plants from the leaves using gas-chromatography (GC) and mass spectrometry (MS). Analysis of vasaka revealed the presence of amrinone, a selective phosphodiesterase III inhibitor effective in the treatment of congestive heart failure; silicic acid associated with bone mineralization, collagen synthesis, skin, hair and nails health atherosclerosis, Alzheimer disease, immune booster; arsenous acid used for treating leukemia; methyltris (trimethylsiloxy)silane which is a potent antibacterial compound; tetrasiloxanedecamethyl- that exhibits antifungal activity. Analysis of guava revealed the presence of copaene (a tricyclic sesquiterpene) that has antioxidant activity, caryophyllene oxide which has relaxation effect, humulene that promotes appetite-suppressing effect and used for weight loss, γ-muurolene that is known for its antibacterial activity and also alloaromadendrene, a sesquiterpenoid with anticancer and antibacterial properties. Importantly, it also contains (±)-norephedrine, an appetite suppressant and used for nasal decongestion. Phenylephrine is used to relieve nasal discomfort caused by colds, allergies, and hay fever, and (-)-isolongifolol, an antioxidant. The data show that both the plants have important bioactive molecules that can be further exploited for treating human ailments.
- Open Access
- 1 January 2023
- Published by Wiley in Advances in Virology
- Vol. 2023, 1-8
Ethyl Gallate: Promising Cytoprotective against HIV-1-Induced Cytopathy and Antiretroviral-Induced Cytotoxicity
Introduction. HIV-1 infection in cell culture is typically characterized by certain cytopathic effects such as vacuolization of cells and development of syncytia, which further lead to cell death. In addition, the majority of drugs during HIV treatment exhibit serious adverse effects in patients, apart from their beneficial role. During the screening of cytoprotective agents to protect the cells from HIV-1-associated cell death and also drug-associated toxicity, antioxidants from a natural source are assumed to be a choice. A well-known antioxidant, ethyl gallate (EG), was selected for cytoprotection studies which have already been proven as an anti-HIV agent. Objective. The main objective of the study was to explore the cytoprotective potential of EG against HIV-1-induced cytopathic effect and antiretroviral drug toxicity. Methods. DPPH free radical scavenging assay was performed with EG to find the effective concentration for antioxidant activity. HIV-1infection-associated cytopathic effects and further rescue by EG were studied in MT-2 lymphocytes by the microscopic method and XTT cytopathic assays. The cellular toxicity of different antiretroviral drugs in different cell lines and the consequent cytoprotective effectiveness of EG were investigated using an MTT cell viability assay. Results. Like ascorbic acid, EG exhibited promising antioxidant activity. HIV-1 infection of MT2 cells induces cell death often referred to as the cytopathic effect. In addition, the usage of antiretroviral drugs also causes severe adverse effects like cytotoxicity. In this context, EG was tested for its cytoprotective properties against HIV-1-induced cytopathic effect and drug-mediated cellular toxicity. EG reclaimed back the MT2 cells from HIV-1-induced cell death. Antiretroviral drugs, such as ritonavir, efavirinz, AZT, and nevirapine, were tested for their toxicity and induced more cell death at higher concentrations in different tissue models such as the liver (THLE-3), lung (AEpiCM), colorectal (HT-29), and brain (U87 MG). Pretreated cells with EG were rescued from the toxic doses of ART. Conclusion. EG was found to be exhibited cytoprotection not only from HIV-1-linked cell death but also from the chemotoxicity of antiretroviral drugs. Evidently, EG could be a cytoprotective supplement in the management of AIDS along with its enormous antioxidant benefits.
- 1 January 2023
- Published by Wiley in Advances in Virology
- Vol. 2023, 1-8
Open AccessEthyl Gallate: Promising Cytoprotective against HIV-1-Induced Cytopathy and Antiretroviral-Induced Cytotoxicity
Introduction. HIV-1 infection in cell culture is typically characterized by certain cytopathic effects such as vacuolization of cells and development of syncytia, which further lead to cell death. In addition, the majority of drugs during HIV treatment exhibit serious adverse effects in patients, apart from their beneficial role. During the screening of cytoprotective agents to protect the cells from HIV-1-associated cell death and also drug-associated toxicity, antioxidants from a natural source are assumed to be a choice. A well-known antioxidant, ethyl gallate (EG), was selected for cytoprotection studies which have already been proven as an anti-HIV agent. Objective. The main objective of the study was to explore the cytoprotective potential of EG against HIV-1-induced cytopathic effect and antiretroviral drug toxicity. Methods. DPPH free radical scavenging assay was performed with EG to find the effective concentration for antioxidant activity. HIV-1infection-associated cytopathic effects and further rescue by EG were studied in MT-2 lymphocytes by the microscopic method and XTT cytopathic assays. The cellular toxicity of different antiretroviral drugs in different cell lines and the consequent cytoprotective effectiveness of EG were investigated using an MTT cell viability assay. Results. Like ascorbic acid, EG exhibited promising antioxidant activity. HIV-1 infection of MT2 cells induces cell death often referred to as the cytopathic effect. In addition, the usage of antiretroviral drugs also causes severe adverse effects like cytotoxicity. In this context, EG was tested for its cytoprotective properties against HIV-1-induced cytopathic effect and drug-mediated cellular toxicity. EG reclaimed back the MT2 cells from HIV-1-induced cell death. Antiretroviral drugs, such as ritonavir, efavirinz, AZT, and nevirapine, were tested for their toxicity and induced more cell death at higher concentrations in different tissue models such as the liver (THLE-3), lung (AEpiCM), colorectal (HT-29), and brain (U87 MG). Pretreated cells with EG were rescued from the toxic doses of ART. Conclusion. EG was found to be exhibited cytoprotection not only from HIV-1-linked cell death but also from the chemotoxicity of antiretroviral drugs. Evidently, EG could be a cytoprotective supplement in the management of AIDS along with its enormous antioxidant benefits.
- 1 January 2021
- Published by Diva Enterprises Private Limited in Biotech Today
- Vol. 11 (2) , 35-46
Bio-Active Compounds and its Immunomodulatory Properties
Bioactive compounds are secondary metabolites produced by plants.The bioactive compounds like Curcumin, Resveratrol, Quercetin, â-Glucan, Lycopene, Genistein and others isolated from various plants are found to be act very effectively as Immunomodulators. The immunomodulators produce variety of immune responses by stimulating or supressing immune responses. Along with immunomodulatory properties, these bioactive compounds have many other pharmacological properties like anti-inflammatory, Anti-mutagenic, anti-carcinogenic, cardio and neuroprotective and many others. The immunostimulants stimulate the immune responses of immune system when any pathogen enters human body as in case of bacterial and viral infections. These are generally administered when body’s immunity is decreased due to various reasons like aging, health conditions etc., Imunosuppresants supress immune responses of immune system. These are generally administered during organ transplantation to suppress the immune responses. Immunomodulators not only modulate immune responses but also used in treatment of various types of diseases like Malaria, Cancer, Alzeimer’s and to improve functioning of immune system etc., The present article highlights the immunomodulatory effects of Curcumin, Resveratrol, Quercetin, â-Glucan, Lycopene and Genistein.
- 1 January 2021
- Published by Diva Enterprises Private Limited in Biotech Today
- Vol. 11 (2) , 35-46
Bio-Active Compounds and its Immunomodulatory Properties
Bioactive compounds are secondary metabolites produced by plants.The bioactive compounds like Curcumin, Resveratrol, Quercetin, â-Glucan, Lycopene, Genistein and others isolated from various plants are found to be act very effectively as Immunomodulators. The immunomodulators produce variety of immune responses by stimulating or supressing immune responses. Along with immunomodulatory properties, these bioactive compounds have many other pharmacological properties like anti-inflammatory, Anti-mutagenic, anti-carcinogenic, cardio and neuroprotective and many others. The immunostimulants stimulate the immune responses of immune system when any pathogen enters human body as in case of bacterial and viral infections. These are generally administered when body’s immunity is decreased due to various reasons like aging, health conditions etc., Imunosuppresants supress immune responses of immune system. These are generally administered during organ transplantation to suppress the immune responses. Immunomodulators not only modulate immune responses but also used in treatment of various types of diseases like Malaria, Cancer, Alzeimer’s and to improve functioning of immune system etc., The present article highlights the immunomodulatory effects of Curcumin, Resveratrol, Quercetin, â-Glucan, Lycopene and Genistein.
- 16 December 2019
- Published by Springer Nature in VirusDisease
- Vol. 31 (1) , 22-27
In vitro anti-HIV-1 activity of ethyl gallate
In recent years, the exploration for potential inhibitors of HIV has been increased due to the development of drug resistant HIV strains in infected people undergoing antiretroviral agents treatment. In this report, we studied the anti-HIV properties of ethyl gallate (EG) against a panel of HIV-1 strains in in vitro conditions. Different clinical isolates and laboratory strains of HIV-1 were tested for their sensitivity with EG. We found that EG exhibited non-toxic nature over a wide range of cell lines from different tissue origin. Serum proteins have little to no impact on the antiviral activity of EG. In the present study, EG was found to be a promising anti-HIV agent.
- 16 December 2019
- Published by Springer Nature in VirusDisease
- Vol. 31 (1) , 22-27
In vitro anti-HIV-1 activity of ethyl gallate
In recent years, the exploration for potential inhibitors of HIV has been increased due to the development of drug resistant HIV strains in infected people undergoing antiretroviral agents treatment. In this report, we studied the anti-HIV properties of ethyl gallate (EG) against a panel of HIV-1 strains in in vitro conditions. Different clinical isolates and laboratory strains of HIV-1 were tested for their sensitivity with EG. We found that EG exhibited non-toxic nature over a wide range of cell lines from different tissue origin. Serum proteins have little to no impact on the antiviral activity of EG. In the present study, EG was found to be a promising anti-HIV agent.
- 1 January 2018
- Published by SAGE Publications in Pharmacognosy Magazine
- Vol. 14 (57) , 384-S392
Identification of phytoconstituents of Memecylon sisparense gamble leaf and evaluation against cisplatin-induced oxidative renal damage in mice
Background: Memecylon sisparense Gamble (MSG) belongs to Melastomataceae family, having a wide range of pharmacological activities such as antioxidant, hepatoprotective, and anti-inflammatory. Objective: The present study aimed for the first time toward the identification of biologically active compounds in MSG leaf ethyl acetate extract (MSGLEAE) by gas chromatography–mass spectrometry (GC-MS) analysis and compared with docking studies along with its nephroprotective activity against cisplatin (CP)-induced nephrotoxicity in mice. Materials and Methods: MSGLEAE was subjected to GC-MS analysis and molecular docking studies. Swiss albino male mice were treated with MSGLEAE (250, 500 mg/kg, PO) against CP 12 mg/kg IP evaluated for nephroprotective activity. The changes in renal tissue were assessed from serum biochemical renal toxicity, antioxidant stress markers along with histopathological studies. Results: Out of 41 compounds identified, 20 were found having biological activities such as nephroprotective, hepatoprotective, anticancer, antioxidant, and antimicrobial and inhibition of uric acid production. The nephroprotective active compounds (N,N,O-triacetylhydroxylamine, 2(4H)-benzofuranone, 5,6,7,7a-tetrahydro-4,4,7a-trimethyl-, N-{(4-hydroxy-3-methoxyphenyl) methyl}-8-methyl-6-nonenamide) had shown binding energy of −5.27, −5.98, −5.27 (ΔG(Kcal/mol)), respectively, in docking studies. MSGLEAE showed a significant protective effect against CP-induced nephrotoxicity because of the identified compounds by reducing the oxidative stress in renal tissue evident by histopathological studies. Conclusion: This is the first ever report in terms of identification of bioactive constituents in MSGLEAE. Pretreatment has a significant therapeutic benefit during CP therapy by inhibiting oxidative stress, enhancing nephroprotective activity. Abbreviations used: MSGLEAE: Memecylon sisparense Gamble leaf ethyl acetate extract; CP: Cisplatin; BUN: Blood urea nitrogen; SOD: Superoxide dismutase; CAT: Catalase; GSH: Glutathione; NO: Nitric oxide; MDA: Malondialdehyde; IAEC: Institutional Animal Ethics Committee; TCA: Trichloroacetic acid; DTNB: 5,51-dithiobis-2-nitrobenzoic acid; FC: Folin–Ciocalteu reagent; SNP: Sodium nitroprusside; H and E: Hematoxylin and eosin.
- 1 January 2018
- Published by SAGE Publications in Pharmacognosy Magazine
- Vol. 14 (57) , 384-S392
Identification of phytoconstituents of Memecylon sisparense gamble leaf and evaluation against cisplatin-induced oxidative renal damage in mice
Background: Memecylon sisparense Gamble (MSG) belongs to Melastomataceae family, having a wide range of pharmacological activities such as antioxidant, hepatoprotective, and anti-inflammatory. Objective: The present study aimed for the first time toward the identification of biologically active compounds in MSG leaf ethyl acetate extract (MSGLEAE) by gas chromatography–mass spectrometry (GC-MS) analysis and compared with docking studies along with its nephroprotective activity against cisplatin (CP)-induced nephrotoxicity in mice. Materials and Methods: MSGLEAE was subjected to GC-MS analysis and molecular docking studies. Swiss albino male mice were treated with MSGLEAE (250, 500 mg/kg, PO) against CP 12 mg/kg IP evaluated for nephroprotective activity. The changes in renal tissue were assessed from serum biochemical renal toxicity, antioxidant stress markers along with histopathological studies. Results: Out of 41 compounds identified, 20 were found having biological activities such as nephroprotective, hepatoprotective, anticancer, antioxidant, and antimicrobial and inhibition of uric acid production. The nephroprotective active compounds (N,N,O-triacetylhydroxylamine, 2(4H)-benzofuranone, 5,6,7,7a-tetrahydro-4,4,7a-trimethyl-, N-{(4-hydroxy-3-methoxyphenyl) methyl}-8-methyl-6-nonenamide) had shown binding energy of −5.27, −5.98, −5.27 (ΔG(Kcal/mol)), respectively, in docking studies. MSGLEAE showed a significant protective effect against CP-induced nephrotoxicity because of the identified compounds by reducing the oxidative stress in renal tissue evident by histopathological studies. Conclusion: This is the first ever report in terms of identification of bioactive constituents in MSGLEAE. Pretreatment has a significant therapeutic benefit during CP therapy by inhibiting oxidative stress, enhancing nephroprotective activity. Abbreviations used: MSGLEAE: Memecylon sisparense Gamble leaf ethyl acetate extract; CP: Cisplatin; BUN: Blood urea nitrogen; SOD: Superoxide dismutase; CAT: Catalase; GSH: Glutathione; NO: Nitric oxide; MDA: Malondialdehyde; IAEC: Institutional Animal Ethics Committee; TCA: Trichloroacetic acid; DTNB: 5,51-dithiobis-2-nitrobenzoic acid; FC: Folin–Ciocalteu reagent; SNP: Sodium nitroprusside; H and E: Hematoxylin and eosin.